Stay updated on CPX-351 and Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-15T00:15:39.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T21:51:18.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The website has removed a detailed section regarding data download options, including file formats and various study-related fields.
    Difference
    14%
    Check dated 2024-11-23T06:16:41.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    A new addition was made on November 13, 2024, while content from May 8, 2024, has been removed.
    Difference
    0.6%
    Check dated 2024-11-16T01:56:24.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.
    Difference
    16%
    Check dated 2024-11-08T19:22:01.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.0 to v2.12.1.
    Difference
    0.3%
    Check dated 2024-11-01T11:47:41.000Z thumbnail image

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.